Literature DB >> 23205884

Single-nucleotide gene polymorphisms involving cell death pathways: a study of Chinese patients with lumbar disc herniation.

Zhengming Sun1, Ming Ling, Yanhai Chang, Yuping Huo, Guang Yang, Yuqiang Ji, Yaping Li.   

Abstract

OBJECTIVE: To evaluate the effect of polymorphisms of death pathway genes FAS and FASL on the risk of developing lumbar disc herniation (LDH) in a Northern Chinese population. BACKGROUND DATA: The FAS receptor-ligand system plays a key role to regulate apoptosis of cell. There is evidence that the apoptosis-mediated FAS receptor-ligand system is involved in the pathogenesis of disc degeneration. Some research considered single-nucleotide polymorphisms of FAS-1377G/A, FAS-670A/G, FASL-844T/C, and FASL INV2nt-124A/G may increase the risk of developing cancer. We therefore assess these four single-nucleotide polymorphisms as candidate susceptibility for LDH.
METHODS: A total of 475 patients with LDH and 533 control subjects were selected. Genotypes were determined by polymerase chain reaction-based restriction fragment length polymorphism and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Associations with the risk of LDH were estimated by logistic regression model.
RESULTS: Significant differences were found in genotypic distributions between cases and controls for FASL-844T/C, but not for other three polymorphisms. When compared with CC genotype, subjects with the TT genotype had a higher risk to develop LDH (odds ratio = 3.12; 95% confidence interval: 1.73-5.40). Moreover, an association was found between this genotype of FASL-844TT and more severe grades of disc degeneration. We observed statistically significant interactions between polymorphisms of FASL-844T/C and lumbar load, tobacco smoking, and age.
CONCLUSION: Genetic polymorphisms of FASL-844T/C may be associated with an increased risk of developing disc degeneration and LDH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23205884     DOI: 10.3109/03008207.2012.734878

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  7 in total

1.  [Association of FasL-844T/C gene polymorphism with FasL expression in the nucleus pulposus of degenerative lumbar intervertebral discs].

Authors:  Zheng-Ming Sun; Pengmaojiacuo Pengmaojiacuo; Hong-Hai Xu; Yan-Hai Chang; Xue-Yuan Wu; Xiang-Hui Dong; Ming Ling
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-07-20

2.  A genetic variant in COL11A1 is functionally associated with lumbar disc herniation in Chinese population.

Authors:  Wenjun Liu; Guisen Sun; Longsheng Guo; Lulu Wang; Weiqiang Fan; Minglei Lang; Dan Chen; Xinhao Yi
Journal:  J Genet       Date:  2017-12       Impact factor: 1.166

3.  Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.

Authors:  Haiguang Zhang; Junbo Ge; Huanyu Hong; Lili Bi; Zhengwen Sun
Journal:  World J Surg Oncol       Date:  2017-04-07       Impact factor: 2.754

4.  Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis.

Authors:  Donghua Huang; Jinrong Xiao; Xiangyu Deng; Kaige Ma; Hang Liang; Deyao Shi; Fashuai Wu; Zengwu Shao
Journal:  BMC Musculoskelet Disord       Date:  2018-05-07       Impact factor: 2.362

5.  Meta-Analysis of the Association Between FAS Ligand and TRAIL Genetic Polymorphisms and Intervertebral Disc Degeneration Susceptibility in Chinese Han population.

Authors:  Xin Huang; Weiyue Zhang; Zengwu Shao
Journal:  Spine (Phila Pa 1976)       Date:  2018-11-15       Impact factor: 3.241

Review 6.  Genetic background of degenerative disc disease in the lumbar spine.

Authors:  Yoshiharu Kawaguchi
Journal:  Spine Surg Relat Res       Date:  2018-02-28

Review 7.  Targeted therapy for intervertebral disc degeneration: inhibiting apoptosis is a promising treatment strategy.

Authors:  Xiao-Bo Zhang; Yi-Cun Hu; Peng Cheng; Hai-Yu Zhou; Xiang-Yi Chen; Ding Wu; Rui-Hao Zhang; De-Chen Yu; Xi-Dan Gao; Jin-Tao Shi; Kai Zhang; Shao-Long Li; Peng-Jie Song; Ke-Ping Wang
Journal:  Int J Med Sci       Date:  2021-05-27       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.